Myhre syndrome is a rare autosomal dominant disorder caused by a narrow spectrum of missense mutations in the SMAD4 gene. Typical features of this disorder are distinctive facial appearance, deafness, intellectual disability, cardiovascular abnormalities, short stature, short hands and feet, compact build, joint stiffness, and skeletal anomalies. The clinical features generally appear during childhood and become more evident in older patients. Therefore, the diagnosis of this syndrome in the first years of life is challenging. We report a 2-year-old girl diagnosed with Myhre syndrome by whole exome sequencing (WES) that revealed the recurrent p.Ile500Val mutation in the SMAD4 gene. Our patient presented with growth deficiency, dysmorphic features, tetralogy of Fallot, and corectopia (also known as ectopia pupillae). The girl we described is the youngest patient with Myhre syndrome. Moreover, corectopia and tetralogy of Fallot have not been previously reported in this disorder.
pericardial disease although congenital heart defects have also been reported (Lin et al., 2016; Starr et al., 2015) . Patients with Myhre syndrome might develop various long-term and life-threatening complications including systemic hypertension, cardiomyopathy, pericarditis, laryngo-tracheal stenosis, and pulmonary insufficiency (Garavelli et al., 2016; Lin et al., 2016; Starr et al., 2015) .
Myhre syndrome is caused by recurrent missense heterozygous mutations affecting the Ile500 residue of the SMAD4 gene that encodes a tumor-suppressor protein affecting the transforming growth factor β (TGF-β) signaling pathway (Caputo et al., 2012; Le Goff et al., 2011; Piccolo et al., 2014) . A mutation in Arg496 has been described in a minority of patients (Caputo et al., 2014; Michot et al., 2014) . We report a 2-year-old female child harboring a de novo mutation affecting Ile500 who presented with poor growth, dysmorphic features, corectopia (also known as ectopia pupillae), and tetralogy of Fallot (TOF). This case is remarkable for the early diagnosis and the ocular and cardiac abnormalities which have not been previously reported in individuals with Myhre syndrome.
| CASE REPORT
The child was born to non-consanguineous parents by ceasarean section after 38 weeks of gestation complicated by intrauterine growth retardation and a prenatal diagnosis of TOF. Her birth weight was 2.3 kg (3th centile). The diagnosis of classic TOF and right aortic arch was confirmed by echocardiogram at birth. She underwent cardiac catheterizations at 3 and 19 days of life for pulmonary balloon dilation that was only partially successful and was followed by 5 mm coronary stent positioning into the right ventricular outflow tract to increase pulmonary blood flow. An aorta of normal caliber was noted during aortic catheterization. At 7 months of age, she underwent complete repair of the TOF with closure of the ventricular septum defect, trans-anular pulmonary patch, and left pulmonary artery patch repair. At the age of 2 years and 10 months, she underwent another surgical intervention for correction of right ventricular outflow tract obstruction. At chest re-opening, a diffusely fibrotic scar tissue around the great vessels, on the epicardium, and on the transanular patch was observed.
At the age of 11 months, she was found to have a tense abdomen and an abdominal ultrasound revealed ascites that resolved within approximately 24 hr following treatment with diuretics and a phosphodiesterase III inhibitor (enoximone). Liver and function tests did not reveal any abnormalities and the cause for the ascites remained (142, 825, 890, 668) , and 15q14 of 71 kb (34, 735, 806, 953) 62, 460, 654, 363) that were all overlapping with copy number variants detected in controls and thus, they were interpreted as non-pathogenic.
| Whole exome sequencing
After informed consent, the child was enrolled in the Telethon Undiagnosed Program (TUDP) and underwent whole exome sequencing (WES). A total of 56,434 high-quality variants were identified in the proband. Of these variants, 50,825 were single nucleotide variants, 5,609 were indels, 10,625 were predicted to impact a protein sequence, and 510 were also rare (frequency <0.01) according to population database queries. Of these, 14 variants were de novo, 2 were X-linked, and 461 were homozygous or compound-heterozygous, considering trio segregation.
The subsequent prioritization process was based on the selection of variants with potential loss-of-function effect, with higher Combined Annotation Dependent Depletion (CADD) score (Kircher et al., 2014) , and involving genes related to the patient Deml et al. (2015) phenotype. As top candidate, one de novo (g.chr18:48604676A>G according to GRCh37) variant in SMAD4 (NM_005359.5: c.1498A>G) was identified. This variant causes the p.Ile500Val substitution repeatedly found in Myhre syndrome patients (Caputo et al., 2012; Le Goff et al., 2011) . The mutation was confirmed by Sanger sequencing. Both parents did not harbor the mutation. Targeted analysis of the reads corresponding to genes associated to anterior segment dysgenesis (COL1A1, COL4A, B3GALTL, BMP4, BMP7, CYP1B1, FOX2C1, FOXC2, FOXE3, JAG1, LAMB2, PAX6, PIK3CA, PITX2, PITX3) revealed no variants.
| DISCUSSION
Previously, the youngest Myhre syndrome patient reported was a 3-year-old boy lacking the distinctive findings such as restricted joint movement, compact build and dysmorphic features who was part of a series reporting the results of WES (Need et al., 2012) . Early clinical diagnosis of Myhre syndrome in infancy is difficult because several features become evident in late childhood and thus, WES is an effective method for recognition of this disorder.
Ocular involvement with cataracts, strabismus, retinitis pigmentosa, maculopathy, papilledema, and pseudo-papilledema has been reported in Myhre syndrome (Table 1) . However, corectopia has not yet been reported. The lack of variants in known genes associated with anterior segment dysgenesis suggests that the SMAD4 mutation is responsible for the corectopia. Corectopia is generally associated with lens dislocation (Colley et al., 1991) , but the child we report herein presented with corectopia without lens dislocation. Although it has not been reported so far in Myhre patients, corectopia with or without lens dislocation has been described in other connective tissue disorders including Marfan syndrome, Weill-Marchesani syndrome (Colley et al., 1991) , and ADAMTSL4-related disorder (Chandra et al., 2012; Christensen et al., 2010; Sharifi, Tjon-Fo-Sang, Cruysberg, & Maat-Kievit, 2013) , which are all characterized by defects of TGF-β pathway (Table 2) .
Moreover, corectopia has been reported in Fbn2 and Adamtsl4 null mice showing disruption of extracellular microfibril biogenesis (Collin et al., 2015; Shi, Tu, Mecham, & Bassnett, 2013) .
Cardiovascular anomalies have been reported in approximately
70% of patients with Myhre syndrome (Lin et al., 2016) . The most frequent congenital heart defects are large patent ductus arteriosus, atrial and ventricular septal defects, and stenosis of aortic and mitral valves (Lin et al., 2016) . Among these defects, TOF has not been reported. Moreover, patients with Myhre syndrome can develop recurrent pericardial effusion, constrictive pericarditis and cardiomyopathy (Lin et al., 2016; Picco et al., 2013) . Given the occurrence of such complications, a timely diagnosis of Myhre syndrome is important.
In conclusion, we report a young child with Myhre syndrome due to SMAD4 mutation that presented corectopia and TOF, two features that have not been previously reported in Myhre syndrome patients. 
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